Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18722306 | 0.97 | ESR2 (0.45) | ESR2ESR1GAAMAPTTDP1 | |
| SCHEMBL22111431 | 0.87 | ESR2 (0.43) | ESR2ESR1TDP1HSD17B1ACHE | |
| SCHEMBL19618901 | 0.87 | ESR2 (0.43) | ESR2ESR1TDP1HSD17B1ACHE | |
| SCHEMBL15026010 | 0.87 | NPC1 (0.49) | ESR2ESR1GAAMAPTTDP1 | |
| SCHEMBL11966921 | 0.87 | ESR2 (0.39) | ESR2ESR1GAAMAPTTDP1 | |
| SCHEMBL1513689 | 0.86 | ESR2 (0.60) | ESR2ESR1TDP1TP53HSD17B1 | |
| SCHEMBL5597351 | 0.86 | ACHE (0.50) | ESR2ESR1GAAMAPTTDP1 | |
| SCHEMBL29565280 | 0.86 | ACHE (0.50) | ESR2ESR1GAAMAPTTDP1 | |
| SCHEMBL14850871 | 0.86 | KMT2A (0.46) | ESR2ESR1GAAMAPTMEN1 | |
| SCHEMBL26463820 | 0.86 | MAPT (0.44) | ESR2ESR1GAAMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1028516-C | Composition based of methylating and benzylating derivatives of diphenylmethane and application as dielectric | ATOCHEM (FR) | 1995-05-24 | — | — | CN | claimed |
| CN-1054415-A | With ditan methylate and the benzyl derivative is the composition of main component and as dielectric application | ATOCHEM (FR) | 1991-09-11 | — | — | CN | claimed |
| EP-3883522-B1 | USE OF A POLYETHER-MODIFIED POLYDIMETHYL SILOXANE FOR REDUCING THE STICKINESS OF A DENTAL IMPRESSION COMPOSITION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-01-08 | — | — | EP | disclosed |
| US-11872292-B2 | Cationically and radiation curable composition | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-01-16 | — | — | US | disclosed |
| WO-2022186150-A1 | CORE-SHEATH COMPOSITE FIBER, PRODUCTION METHOD THEREFOR, AND FIBER STRUCTURE | 株式会社クラレ | 2022-09-09 | — | — | WO | disclosed |
| EP-3319580-B1 | KIT OF PARTS CONTAINING A CATIONICALLY HARDENABLE COMPOSITION AND USE AS DENTAL RETRACTION MATERIAL | 3M INNOVATIVE PROPERTIES CO (US) | 2022-04-06 | — | — | EP | disclosed |
| EP-3515396-B1 | CATIONICALLY AND RADIATION CURABLE COMPOSITION | 3M INNOVATIVE PROPERTIES CO (US) | 2022-01-05 | — | — | EP | disclosed |
| EP-3883522-A1 | CURABLE COMPOSITION CONTAINING A POLYETHER-MODIFIED POLYDIMETHYL SILOXANE | 3M Innovative Properties Company (US) | 2021-09-29 | — | — | EP | disclosed |
| US-10952933-B2 | Kit of parts containing a cationically hardenable composition and use as dental retraction material | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-03-23 | — | — | US | disclosed |
| EP-2459151-B1 | CATIONICALLY HARDENABLE DENTAL COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2021-03-03 | — | — | EP | disclosed |
| US-20200390778-A1 | COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES | OXALURX, INC. | 2020-12-17 | — | — | US | disclosed |
| EP-0980410-A1 | THERMAL FLUID BLENDS CONTAINING 1,2,3,4-TETRAHYDRO(1-PHENYLETHYL)NAPHTHALENE | THE DOW CHEMICAL COMPANY (US) | 2000-02-23 | — | — | EP | disclosed |
| WO-1998050483-A1 | THERMAL FLUID BLENDS CONTAINING 1,2,3,4-TETRAHYDRO(1-PHENYLETHYL)NAPHTHALENE | THE DOW CHEMICAL COMPANY (US) | 1998-11-12 | — | — | WO | disclosed |
| CN-1028516-C | Composition based of methylating and benzylating derivatives of diphenylmethane and application as dielectric | ATOCHEM (FR) | 1995-05-24 | — | — | CN | disclosed |
| CN-1018732-B | POLYARYLALKANE OLIGOMER COMPOSITIONS AND PROCESS FOR THEIR MANUFACTURE | ATOCHEM (FR) | 1992-10-21 | — | — | CN | disclosed |
| CN-1016334-B | Process for the production of polyarylalkane oligomers containing xylene units | ATOCHEM (FR) | 1992-04-22 | — | — | CN | disclosed |
| CN-1054415-A | With ditan methylate and the benzyl derivative is the composition of main component and as dielectric application | ATOCHEM (FR) | 1991-09-11 | — | — | CN | disclosed |
| CN-1054415-A | With ditan methylate and the benzyl derivative is the composition of main component and as dielectric application | ATOCHEM (FR) | 1991-09-11 | — | — | CN | disclosed |
| CN-1031365-A | The composition of multiple aromatic yl alkane oligomer and its production method | ATOCHEM (FR) | 1989-03-01 | — | — | CN | disclosed |
| CN-1031219-A | Contain the composition of multiple aromatic yl alkane oligomer of xylene chain link and its production method | ATOCHEM (FR) | 1989-02-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10952933-B2 | Kit of parts containing a cationically hardenable composition and use as dental retraction material | SET, SETDB1, DNMT3A | ESR2 3821/4885ESR1 4014/4885GAA 2715/4885 |
| US-11872292-B2 | Cationically and radiation curable composition | RAD51, SMARCA1, SMARCA4 | ESR2 2547/4885ESR1 2273/4885GAA 2560/4885 |
| US-20200390778-A1 | COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES | XDH, PNPO, LOX | ESR2 4344/4885ESR1 4780/4885GAA 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.